Dear Colleagues,
<br>
<br>We would like to invite you to submit a paper to our session
<br>“‘SMALLNESS’ AS AN ANALYTIC CATEGORY IN MEDICAL ANTHROPOLOGY" (Session
<br>3) at the VANDA (VIENNA ANTHROPOLOGY DAYS) 2020 (SEPTEMBER 28-OCTOBER 1,
<br>2020).
<br>
<br>VANDA_ _is an international ONLINE conference. It aims to bring together
<br>scholars from various fields of anthropology, social sciences and
<br>humanities.
<br>
<br>ABSTRACT: A notion of "smallness" plays a crucial role in life with and
<br>policies on many diseases, specifically rare disorders but also
<br>epidemics or vaccination coverage. Drawing from conceptualizations of
<br>smallness proposed as an anthropological stronghold by Hannerz &
<br>Gingrich (eds. 2017), this session invites critical contributions that
<br>attend to the issue of smallness, critical numbers, threshold values and
<br>the likes in the medical field.
<br>
<br>Small populations afflicted or small numbers of cases might require
<br>special strategies and programs to be noticed. A 'too small' for
<br>epidemiologists might still have a large impact on the everyday life of
<br>local communities. Stigma might be related to smallness. Following
<br>Hannerz & Gingrich (2017:6), we want to ask how smallness in reference
<br>to health matters "affect(s) life and thought, sensibilities as well as
<br>structures of social relationships, in everyday life as well as in the
<br>context of critical events."
<br>
<br>How do people, governmental, non-governmental, and transnational
<br>organizations perceive smallness regarding afflicted bodies and diseases
<br>in their contexts of time, space, environment, and socio-political
<br>constellations? What anthropological, medical, and public health
<br>strategies and policies are implemented to address research on and/or
<br>treatment of (rare, chronic, communicable) diseases that affect a small
<br>number of people? What is the role of biosocialities (Rabinow 1996,
<br>Gibbon and Novas 2008) in facilitating intimacies, linkages, and
<br>networks within these diseases fields? How is "branding" of small
<br>populations and their unique diseases (Tupasela 2017) utilized in the
<br>context of genetics and biobanking? What is the role of migration in
<br>influencing and destabilizing common ideas about the low prevalence of
<br>certain diseases in any given region or country?
<br>
<br>Deadline for the CALL FOR PAPERS IS JULY 1ST, 2020. Please submit your
<br>abstract (max. 350 words) at:
<br>https://vanda.univie.ac.at/call-for-papers/ [1]
<br>
<br>We look forward to hearing from you.
<br>
<br>Best regards,
<br>
<br>Malgorzata Rajtar (Polish Academy of Sciences) & Eva-Maria Knoll
<br>(Austrian Academy of Sciences)
<br>
<br>---
<br>Dr hab. MaĆgorzata Rajtar
<br>Prof. IFiS/ Associate Professor
<br>Instytut Filozofii i Socjologii PAN/ Institute of Philosophy &
<br>Sociology, Polish Academy of Sciences
<br>mrajtar@ifispan.waw.pl
<br>Osrodek Badan Spolecznych nad Chorobami Rzadkimi/Rare Disease Social
<br>Research Center
<br>http://rdsrc.ifispan.pl/en/
<br>
<br>
<br>Links:
<br>------
<br>[1] https://vanda.univie.ac.at/call-for-papers/
<br>_______________________________________________
<br>EASST's Eurograd mailing list
<br>Eurograd (at) lists.easst.net
<br>Unsubscribe or edit subscription options: http://lists.easst.net/listinfo.cgi/eurograd-easst.net
<br>
<br>Meet us via https://twitter.com/STSeasst
<br>
<br>Report abuses of this list to Eurograd-owner@lists.easst.net
view formatted text
